DNA Brands, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DNAX research report →
Price Chart
About the company
DNA Brands, Inc. operates within the energy drink market, offering a selection of beverages in distinct flavors such as cellular citrus zero sugar, cellular citrus, cryo berry, and molecular melon. These products are supplied to various establishments, including retailers, dining venues, and nightlife spots like bars and clubs.
- CEO
- Adrian Mckenzie Patasar
- IPO
- 2009
- Employees
- 1
- HQ
- Fort Lauderdale, FL, US
Get TickerSpark's AI analysis on DNAX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $171.82K
- P/E
- -1.18
- PEG
- -0.01
- P/S
- 0.00
- P/B
- -0.08
- EV/EBITDA
- -21.52
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 6.80%
- ROIC
- 15.59%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-250,000
- Net Income
- $-523,000+25.6%
- EPS
- $-0.00+80.0%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 1.79
- RSI (14)
- 52
- Avg Volume
- 159.61K
No earnings-call transcripts are available for DNAX yet.
- Free Float
- 100.0%
- Shares Outstanding
- 1.72B
- Float Shares
- 1.72B
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 1, 13 | Fowler Eric | other | 100,000 |
| Jan 1, 15 | Fowler Eric | other | 100,000 |
| Oct 8, 12 | Marks Darren | sell | 47,700 |
| Oct 8, 12 | Leiner Melvin | sell | 100,000 |
| Oct 8, 12 | Leiner Melvin | sell | 357,637 |
| Sep 10, 12 | Leiner Melvin | sell | 134,403 |
| Aug 28, 12 | Marks Darren | sell | 200,000 |
| Aug 3, 12 | Marks Darren | sell | 20,000 |
| Aug 8, 12 | Marks Darren | sell | 20,000 |
| Aug 9, 12 | Marks Darren | sell | 5,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our DNAX coverage
Recent articles, reports, and earnings notes.
No research on DNAX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate DNAX report →